Hero image with Pittsburgh background pittplusme.org/study/1579

Pitt+Me PEARLE Study


Are you over 34 weeks pregnant and plan to deliver your baby at UPMC Magee-Womens Hospital? You may qualify for a research study designed to find out if an investigational device called the Jada™ System can control postpartum hemorrhage (excessive bleeding after delivery). You will only receive the Jada intervention in this study in the rare event that you experience postpartum hemorrhage.


Postpartum hemorrhage (also called PPH) is when a woman has excessive blood loss after delivering a baby. Currently available treatments for PPH include uterine massage, medications, blood transfusions, and surgery, but these interventions can have unwanted side effects and are not always effective. Although PPH is uncommon, it is difficult to predict who will develop the condition because most women have no known risk factors.


The purpose of this research study is to find out if an investigational new device called the Jada™ System can control abnormal bleeding faster than other available options. Jada is a tool placed in the uterus after delivery that works by using gentle suction to contract the uterus and stop the bleeding. Jada is considered investigational because the Food and Drug Administration (FDA) has not approved it for sale.

  • More than 34 weeks pregnant
  • Plan to deliver your baby at UPMC Magee-Womens Hospital


Women who plan to deliver at UPMC Magee-Womens Hospital can be evaluated before their delivery to find out if they are eligible for this research study, but only women who experience postpartum hemorrhage will receive the Jada intervention. Participants who are interested and eligible will be asked to sign the informed consent form.


If you have postpartum hemorrhage, your doctor will do what is most appropriate for your care. First, the doctor will try medicines to try to stop the bleeding. If those medicines don’t work and the doctor decides that you are still a good candidate for the study, the doctor will proceed with using the Jada System. Once inserted, the device will remain in place until the doctor believes it can be removed. If Jada is not effective, your doctor will pursue alternative treatments.


If you have postpartum hemorrhage after delivery and the Jada system is used, and if you also complete a 6-week office visit, you will be compensated $100.

  20182855 - PEARLE: Prospective, Single Arm, Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada™ System in Treating Primary Postpartum Hemorrhage

Age Range
AGE:   18 and Up

Location LOCATION: 
UPMC Magee-Womens Hospital
Phone Number PHONE NUMBER:
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1579
Phone Number PHONE NUMBER:


Hyagriv Simhan

Hyagriv Simhan, MD, MSCR, is professor at the University of Pittsburgh School of Medicine, and chief of the division of maternal-fetal medicine and medical director of obstetrical services at Magee-Womens Hospital of UPMC. His main area of research has been on preterm birth. Because of his efforts to improve patient safety and quality of care, Dr. Simhan has been awarded the Fine Award from the Pittsburgh Regional Health Initiative, and the Achievement Award for Health Care Quality Improvement/Patient Safety from the Hospital Association of Pennsylvania.

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet


This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.